These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 24837011

  • 1. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
    Ding H, Sun Y, Hou Y, Li L.
    Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
    [Abstract] [Full Text] [Related]

  • 2. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
    Sun Y, Ding H, Liu X, Li X, Li L.
    Tumour Biol; 2014 May; 35(5):4469-77. PubMed ID: 24420152
    [Abstract] [Full Text] [Related]

  • 3. Inositol polyphosphate-4-phosphatase type II and rucaparib treatment inhibit the growth of osteosarcoma cells dependent on phosphoinositide 3-kinase/protein kinase B pathway.
    Li D, Yang J, Ma H, Sun C, Feng R.
    J Cell Biochem; 2018 Dec; 119(12):9899-9909. PubMed ID: 30132953
    [Abstract] [Full Text] [Related]

  • 4. MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways.
    Zhou S, Dai Z, Wang L, Gao X, Yang L, Wang Z, Wang Q, Liu Z.
    J Cell Mol Med; 2021 Dec; 25(24):11157-11169. PubMed ID: 34761497
    [Abstract] [Full Text] [Related]

  • 5. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
    Chang SH, Bae JH, Hong DP, Choi KD, Kim SC, Her E, Kim SH, Kang CD.
    J Ethnopharmacol; 2010 Jul 20; 130(2):248-54. PubMed ID: 20438825
    [Abstract] [Full Text] [Related]

  • 6. INPP4B overexpression suppresses migration, invasion and angiogenesis of human prostate cancer cells.
    Chen H, Li H, Chen Q.
    Clin Exp Pharmacol Physiol; 2017 Jun 20; 44(6):700-708. PubMed ID: 28261855
    [Abstract] [Full Text] [Related]

  • 7. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
    Shen P, Sun J, Xu G, Zhang L, Yang Z, Xia S, Wang Y, Liu Y, Shi G.
    Prostate; 2014 Jun 20; 74(9):946-58. PubMed ID: 24737412
    [Abstract] [Full Text] [Related]

  • 8. Loss of INPP4B causes a DNA repair defect through loss of BRCA1, ATM and ATR and can be targeted with PARP inhibitor treatment.
    Ip LR, Poulogiannis G, Viciano FC, Sasaki J, Kofuji S, Spanswick VJ, Hochhauser D, Hartley JA, Sasaki T, Gewinner CA.
    Oncotarget; 2015 Apr 30; 6(12):10548-62. PubMed ID: 25868852
    [Abstract] [Full Text] [Related]

  • 9. Paradoxical and contradictory effects of imatinib in two cell line models of hormone-refractory prostate cancer.
    Cardoso HJ, Vaz CV, Correia S, Figueira MI, Marques R, Maia CJ, Socorro S.
    Prostate; 2015 Jun 15; 75(9):923-35. PubMed ID: 25786656
    [Abstract] [Full Text] [Related]

  • 10. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer.
    Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, Ittmann MM, Weigel NL, Agoulnik IU.
    Cancer Res; 2011 Jan 15; 71(2):572-82. PubMed ID: 21224358
    [Abstract] [Full Text] [Related]

  • 11. [Inhibitory effect of lentiviral vector-mediated SHIP gene transfection on proliferation of leukemia K562 cells and PI3K/Akt pathway regulation].
    Yang L, Luo JM, Liu XJ, Wen SP, Du XY, Yao L.
    Ai Zheng; 2009 Apr 15; 28(4):366-72. PubMed ID: 19622295
    [Abstract] [Full Text] [Related]

  • 12. Doxycycline synergizes with doxorubicin to inhibit the proliferation of castration-resistant prostate cancer cells.
    Zhu C, Yan X, Yu A, Wang Y.
    Acta Biochim Biophys Sin (Shanghai); 2017 Nov 01; 49(11):999-1007. PubMed ID: 28985240
    [Abstract] [Full Text] [Related]

  • 13. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
    Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y, Sun Y.
    J Urol; 2013 Dec 01; 190(6):2278-87. PubMed ID: 23845456
    [Abstract] [Full Text] [Related]

  • 14. The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
    De Blasio A, Musmeci MT, Giuliano M, Lauricella M, Emanuele S, D'Anneo A, Vassallo B, Tesoriere G, Vento R.
    Int J Oncol; 2003 Dec 01; 23(6):1521-8. PubMed ID: 14612922
    [Abstract] [Full Text] [Related]

  • 15. Phenoxodiol inhibits growth of metastatic prostate cancer cells.
    Aguero MF, Venero M, Brown DM, Smulson ME, Espinoza LA.
    Prostate; 2010 Aug 01; 70(11):1211-21. PubMed ID: 20564423
    [Abstract] [Full Text] [Related]

  • 16. YAP is closely correlated with castration-resistant prostate cancer, and downregulation of YAP reduces proliferation and induces apoptosis of PC-3 cells.
    Sheng X, Li WB, Wang DL, Chen KH, Cao JJ, Luo Z, He J, Li MC, Liu WJ, Yu C.
    Mol Med Rep; 2015 Oct 01; 12(4):4867-76. PubMed ID: 26126522
    [Abstract] [Full Text] [Related]

  • 17. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
    Reed DE, Shokat KM.
    Mol Cancer Res; 2017 Jun 01; 15(6):765-775. PubMed ID: 28196852
    [Abstract] [Full Text] [Related]

  • 18. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
    Lee SH, Kang YJ, Sung B, Kim DH, Lim HS, Kim HR, Kim SJ, Yoon JH, Moon HR, Chung HY, Kim ND.
    Int J Oncol; 2014 Mar 01; 44(3):905-11. PubMed ID: 24424889
    [Abstract] [Full Text] [Related]

  • 19. A novel PI3K inhibitor displays potent preclinical activity against an androgen-independent and PTEN-deficient prostate cancer model established from the cell line PC3.
    Shi M, Zhou X, Zhang Z, Wang M, Chen G, Han K, Cao B, Liu Z, Mao X.
    Toxicol Lett; 2014 Aug 04; 228(3):133-9. PubMed ID: 24831963
    [Abstract] [Full Text] [Related]

  • 20. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
    Sun Y, Zhou L, Lv D, Liu H, He T, Wang X.
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun 04; 47(6):422-30. PubMed ID: 25926140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.